Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided suprascapular nerve block for post-stroke hemiplegic shoulder pain: dextrose 5% vs bupivacaine + betamethasone vs placebo
PACTR202512825266164Phase 4Recruiting
- Sponsor
- Ain Shams University
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hemiplegic shoulder pain (PHS) and stroke comparing Dextrose Group, Bupivacaine and Betamethasone Group and Placebo group (3 arms). Primary endpoint: Pain relief after intervention. Started Nov 2025; status: recruiting.
02
Drugs
dextrosebupivacainebetamethasone
03
Conditions
hemiplegic shoulder pain (PHS)stroke
Beyond the preview
Go deeper on PACTR202512825266164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202512825266164.